06.07.2022
Н. В. Муравьева; Б. С. Белов
in the pathogenesis of COVID-19, which is confirmed by the results of numerous studies. However, data on the efficacy
13.03.2022
Е. С. Аронова; Б. С. Белов; Г. И. Гриднева
the course of PCS in rheumatic diseases
Purpose. To characterize the features of the course of COVID-19
30.11.2021
Б. С. Белов; Н. В. Муравьева; М. М. Баранова
infections, viral hepatitis B, yellow fever and COVID-19 used in rheumatological patients. It has been shown
07.08.2021
Е. С. Аронова; Б. С. Белов
in severe COVID-19. The review presents literature data on the efficacy and safety of certain basic anti
14.07.2020
Б. С. Белов; Н. В. Муравьева; Г. М. Тарасова
The disease caused by the new coronavirus COVID-19 is considered by the world community
